ArticleCancer immunology research2015

Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage.

José Medina-Echeverz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.